Pulmonary hypertension (PH) worsens the mortality of the patients with sickle cell disease (SCD). The exact mechanism of PH development/progression in SCD, including the role of tricuspid regurgitation (TR), remains unclear. We herein report an unusual SCD case, complicated by chronic thromboembolic disorder, who developed severe TR and an accelerated progression of PH. Tricuspid valve surgery significantly ameliorated the patient's symptoms and reduced hospital readmission. The early detection and management of the reversible disorder accelerating the PH development in SCD patients may alter the clinical course, improve the quality of life, and potentially affect the long-term outcome.
A 35-year-old African American woman with a history of sickle cell disease (SCD), protein C deficiency and pulmonary embolism (PE) presented with worsening dyspnea on exertion (DOE) and lower extremity edema. She had been frequently admitted for DOE/chest pain, with a clinical diagnosis of "sickle cell crises (SCC)". On this physical examination, her blood pressure was 139/71 mmHg, pulse 82 bpm, O2 Sat 91% at room air, and body weight 191 lbs. She had jugular venous dilation, lower extremity edema, and a pan-systolic murmur (heard in the lower left sternal border). Abnormal laboratory findings included a low plasma hemoglobin level (8.6 g/dL) and elevated pro-brain natriuretic peptide level (7,500 pg/mL). A chest X-ray showed clear lungs and an enlarged right atrium. An electrocardiogram revealed significant right axis deviation. Both the ventilation/ perfusion scan and chest computed tomographic angiography ruled out new PE. A transthoracic echocardiogram (TTE) revealed severe tricuspid regurgitation (TR) with right atrial dilatation (Fig. 1A, B) , which raised a clinical suspicion of Ebstein's anomaly. Repeated TTE 6 month later suggested an increased tricuspid regurgitant jet velocity (TRV) and pulmonary hypertension (PH). During the transesophageal echocardiography study (Fig. 1C, D) , although a patent foramen ovale (PFO) was observed (Fig. 1F) , Ebstein's anomaly was excluded according to the morphology of the anterior leaflet of tricuspid valve (TV) and the insertion site of the septal leaflet of TV. The TV was severely calcified with a damaged (bifurcated) anterior cuspid (Fig. 1E ). According to the patient's clinical condition and repeated echocardiographic examination, the structurally abnormal TV with severe TR was most likely the cause of the significantly worsened PH, which was unlikely to be reversed by PH medical treatment alone. Furthermore, the existence of an atrial shunt raised the concern of paradoxical embolism. Therefore, tricuspid valve surgery was performed. An original attempt to repair the valve failed to significantly reduce the severity of TR, which necessitated a valve replacement. In addition, PFO closure was performed ( Fig. 2A-D) . The pathological examination revealed that was severely damaged. After TVR, the patient's PH improved, and the sizes of the RA/RV were reduced ( Fig. 2E-H) . During the two-year follow-up, this patient has had only one hospitalization for SCC. Her physical exercise tolerance additionally improved. The repeated echocardiograms have consistently shown the amelioration of PH.
Discussion
The TV damage with severe TR in this young SCD patient was not caused by Ebstein's anomaly. The postulated etiology was either previously unrecognized infective endocarditis from the recurrent blood transfusions for her SCD anemia or non-bacterial endocarditis/embolism from chronic thromboembolic events secondary to the protein C deficiency (1). According to her clinical and imaging data, the severe TR had likely become the most important contributor to the accelerated PH progression, clinical deterioration, and frequent hospital readmissions. Furthermore, the increased right ventricular pressure and transient right to left shunting through the PFO could have enhanced the respiratory difficulties and hypoxia (2, 3) . Therefore, the timely management of TR became crucial.
PH develops in up to 30% of SCD patients and is considered to be a marker of early mortality (4, 5) . The mechanisms underlying the PH development in SCD include pulmonary vasoconstriction secondary to reduced nitric oxide availability (scavenged by free hemoglobin), the release of arginase by hemolytic red blood cells, chronic hypoxia, iron overload, high cardiac output and asplenism (6, 7) . Although increased echocardiography-derived TRV has long been considered to be an important marker for the PH development and increased mortality in SCD (8) , the specific role of TR itself in the development and progression of PH in the patients with SCD has not yet been defined. Due to the increased pulmonary resistance and afterload in the SCD patients, the regurgitant volume of TR may increase disproportionately to the actual effective regurgitant orifice area of TR (9) . This "functional" TR can increase the RV volume overload and structural remodeling, further worsening the structural abnormality of the TV. This "the worse, the worse" condition would certainly accelerate the PH develop- ment in SCD. Although no consensus has currently been reached on the indications and timing of surgery for TR in SCD patients, the surgical correction of TR should be promptly advocated to break this vicious cycle in these "high-risk" patients, to decelerate the progression of PH, and potentially to improve the long-term outcome.
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